Introduction: Striated duct adenoma (SDA) is a rare benign salivary gland tumor with a recently described genetic signature. Recurrent oncogenic mutations affecting the IDH2 gene differentiate SDA from its primary differential diagnosis of canalicular adenoma. Here, we report a case of SDA affecting the parotid gland with IDH1/2 mutation-specific immunohistochemical positivity. Additionally, we provide a scoping review developed according to the Cochrane Methodology and reported following the Joana Briggs Institute (JBI) checklist to synthesize all previously published cases of SDA. The review protocol was registered on the Open Science Framework (OSF) platform ( https://osf.io/7mztg ). The searches were performed using Medline, Embase, Web of Science, and LILACS, with no date or language limit. Studies were evaluated for eligibility, extracted, and compiled in a narrative form. Seven studies with 20 patients with SDA, including ours, were analyzed. The tumors mainly affected the parotid gland (13/20) in patients with a mean age of 62 years and did not display sex predilection. Swelling was the leading clinical symptom. The mean follow-up duration was 26 months with no recurrence or metastasis after resection.

Conclusion: Awareness of the clinicopathological features and the use of IDH1/2 mutation-specific immunohistochemistry are pivotal for the consistent identification of SDA, and assessment for true biological potential will require increased follow-up and scrutiny.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11442710PMC
http://dx.doi.org/10.1007/s12105-024-01696-5DOI Listing

Publication Analysis

Top Keywords

striated duct
8
duct adenoma
8
scoping review
8
parotid gland
8
idh1/2 mutation-specific
8
sda
6
adenoma case
4
case report
4
report scoping
4
review introduction
4

Similar Publications

Striated Duct Adenoma: A Case Report and a Scoping Review.

Head Neck Pathol

September 2024

Faculty of Medical Sciences of Minas Gerais, Alameda Ezequiel Dias, 275, Belo Horizonte, MG, Brazil.

Introduction: Striated duct adenoma (SDA) is a rare benign salivary gland tumor with a recently described genetic signature. Recurrent oncogenic mutations affecting the IDH2 gene differentiate SDA from its primary differential diagnosis of canalicular adenoma. Here, we report a case of SDA affecting the parotid gland with IDH1/2 mutation-specific immunohistochemical positivity.

View Article and Find Full Text PDF

Striated duct adenoma: The cytological description of a rare entity.

Cytopathology

January 2025

Department of Surgical Pathology, Health Research Institute "San Carlos" (IdISCC), Hospital Universitario Clínico San Carlos, Universidad Complutense de Madrid, Madrid, Spain.

Introduction: Striated duct adenoma is a benign salivary gland tumour recently recognized by the World Health Organization. To date, no report has described the cytological features of this entity.

Materials And Methods: We report the case of a 60-year-old woman with a tumour in the right parotid gland with a diameter greater than 2.

View Article and Find Full Text PDF

With the advancement of molecular testing and the routine use of immunohistochemical stains, salivary gland tumours previously categorized as adenoma or adenocarcinoma, not otherwise specified, are being reclassified with distinct diagnoses. Newly recognized benign entities include: sclerosing polycystic adenoma, keratocystoma, intercalated duct hyperplasia and adenoma, and striated duct adenoma. Newly recognized malignant salivary gland tumours include: microsecretory adenocarcinoma, sclerosing microcytic adenocarcinoma, and mucinous adenocarcinoma.

View Article and Find Full Text PDF

Fexofenadine is a newly introduced oral non-sedating agent used for allergic diseases. We sought to investigate the effects of the use of fexofenadine on the salivary gland of adult male albino rats. 30 adult male albino rats were classified randomly into 3 groups, as follows: Group A (control group) which consisted of 10 healthy rats.

View Article and Find Full Text PDF

[Salivary gland tumors: 2022 WHO blue book and beyond].

Ann Pathol

May 2024

Service d'anatomie et cytologie pathologiques, University Hospital Centre Nantes, Nantes université, CHU de Nantes, 44000 Nantes, France; Inserm, INCIT, UMR 1302/EMR6001, CNRS, Immunology and New Concepts in ImmunoTherapy, Nantes, France. Electronic address:

Article Synopsis
  • * A new benign tumor, keratocystoma, was introduced, while sclerosing polycystic adenosis was reclassified as a tumoral entity and now termed sclerosing polycystic adenoma.
  • * Significant changes include doubts about oncocytic carcinoma's existence, the emergence of microsecretory and microcystic sclerosing adenocarcinomas as new malignant entities, and the recognition of primary mucinous adenocarcinoma as a distinct type.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!